Biora Therapeutics, Inc. Shareholders' Equity
Biora Therapeutics, Inc. had Shareholders' Equity of -$106.63 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-11-14
- 2024-09-30: Stockholders' Equity Attributable to Parent -$106.63M.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$89.32M.
- 2024-03-31: Stockholders' Equity Attributable to Parent -$100.19M.
- 2023-12-31: Stockholders' Equity Attributable to Parent -$101.42M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-09-30 | -$106.63M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$89.32M 10-Q · filed 2024-11-14 |
| 2024-03-31 | -$100.19M 10-Q · filed 2024-11-14 |
| 2023-12-31 | -$101.42M 10-Q · filed 2024-11-14 |
| 2023-09-30 | -$118.79M 10-Q · filed 2024-11-14 |
| 2023-06-30 | -$120.88M 10-Q · filed 2024-11-14 |
| 2023-03-31 | -$105.00M 10-Q · filed 2024-11-14 |
| 2022-12-31 | -$102.29M 10-Q · filed 2024-11-14 |
| 2022-09-30 | -$97.44M 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$96.11M 10-Q · filed 2023-11-13 |
| 2022-03-31 | -$93.19M 10-Q · filed 2023-11-13 |
| 2021-12-31 | -$84.98M 10-K · filed 2024-04-01 |
| 2021-09-30 | -$176.97M 10-Q · filed 2022-11-14 |
| 2021-06-30 | -$139.61M 10-Q · filed 2022-11-14 |
| 2021-03-31 | -$125.51M 10-Q · filed 2022-11-14 |
| 2020-12-31 | -$106.99M 10-K · filed 2023-03-30 |
| 2020-09-30 | -$60.42M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$17.16M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$84.79M 10-Q · filed 2021-11-10 |
| 2019-12-31 | -$83.87M 10-K · filed 2022-03-28 |
| 2019-09-30 | -$89.07M 10-Q · filed 2020-11-09 |
| 2019-06-30 | -$56.64M 10-Q · filed 2020-11-09 |
| 2019-03-31 | -$40.94M 10-Q · filed 2020-11-09 |
| 2018-12-31 | -$36.97M 10-K · filed 2021-03-18 |